Evidence map›Paper›PMID 31197678›Full record

ArticleMetabolic brain disease2019

Mitochondrial oxidative stress-induced brain and hippocampus apoptosis decrease through modulation of caspase activity, Ca

Zeki Serdar Ataizi, Kemal Ertilav, Mustafa Nazıroğlu

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Montelukast reduced docetaxel-induced peripheral neuropathy in rats by altering oxidative stress, histopathological damage, and gene expressions.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025
    Article
  3. Article
  4. Trace elements and metal nanoparticles: mechanistic approaches to mitigating chemotherapy-induced toxicity-a review of literature evidence.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Review
  5. The Protective Effect of the Supplementation with an Extract fromInternational journal of molecular sciences · 2024
    Article
  6. Antioxidant potential of nanomaterials.Turkish journal of biology = Turk biyoloji dergisi · 2023
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zeki Serdar AtaiziDepartmant of Neurosurgery, Yunus Emre General State Hospital, Eskişehir, Turkey.
Kemal ErtilavDepartmant of Neurosurgery, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey.
Mustafa NazıroğluNeuroscience Research Center, Suleyman Demirel University, Isparta, Turkey. mustafanaziroglu@sdu.edu.tr.ORCID 0000-0003-0887-6974
Süleyman Demirel University · TREskişehir City Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Docetaxel (DOCE) is widely used to treat several types of glioblastoma. Adverse effects DOCE seriously limit its clinical use in several tissues. Its side effects on brain cortex and hippocampus have not been clarified yet. Limited data indicated a protective effect of melatonin (MLT) and selenium (SELEN) on DOCE-induced apoptosis, Ca

Indexed as

AnimalsAntioxidantsApoptosisBrainCalciumCaspasesCytokinesDocetaxelGlutathioneGlutathione PeroxidaseHippocampusLipid PeroxidationMelatoninMiceMitochondriaNeuroprotective AgentsAntioxidantsCalciumCaspasesCytokinesDocetaxelGlutathioneGlutathione PeroxidaseMelatoninNeuroprotective AgentsReactive Oxygen SpeciesSeleniumTRPM Cation ChannelsApoptosisDocetaxelHippocampusInflammationMelatoninMitochondrial oxidative cytotoxicity

Identifiers

PMID31197678
OpenAlexW2950125503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.